QSZY(SH:600103)2025-04-28 10:10Financial Performance - The company's operating revenue for Q1 2025 was CNY 627,288,437.05, a decrease of 5.93% compared to CNY 666,845,843.31 in the same period last year[4]. - Net profit attributable to shareholders increased by 41.63% to CNY 30,686,917.75 from CNY 21,667,479.93 year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses rose by 47.33% to CNY 21,397,477.34 compared to CNY 14,523,097.63 in the previous year[4]. - Basic earnings per share increased by 41.84% to CNY 0.0139 from CNY 0.0098 year-on-year[4]. - Total revenue for Q1 2025 was CNY 627.29 million, a decrease of 5.9% compared to CNY 666.85 million in Q1 2024[22]. - Net profit for Q1 2025 reached CNY 35.40 million, an increase of 39.1% from CNY 25.45 million in Q1 2024[23]. - Operating profit for Q1 2025 was CNY 44.05 million, up 51.7% from CNY 29.05 million in Q1 2024[23]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 6,228,053,681.33, a decrease of 2.22% from CNY 6,369,720,116.09 at the end of the previous year[5]. - The total assets as of March 31, 2025, were CNY 5,168,955,757.41, a decrease from CNY 5,367,934,749.97 at the end of 2024[30]. - Total liabilities decreased to CNY 1.89 billion in Q1 2025 from CNY 2.06 billion in Q1 2024[19]. - Total liabilities decreased to CNY 1,645,615,046.63 as of March 31, 2025, from CNY 1,870,119,334.89 at the end of 2024[31]. - Shareholders' equity increased to CNY 4.34 billion in Q1 2025 from CNY 4.31 billion in Q1 2024[19]. Cash Flow - The net cash flow from operating activities improved by 8.45%, reaching -CNY 20,106,352.46 compared to -CNY 21,961,212.73 in the same period last year[4]. - Cash inflow from operating activities for Q1 2025 was CNY 557,458,128.89, an increase from CNY 539,624,734.60 in Q1 2024, representing a growth of approximately 1.5%[26]. - Net cash flow from operating activities was negative CNY 20,106,352.46 in Q1 2025, slightly improved from negative CNY 21,961,212.73 in Q1 2024[27]. - Cash inflow from investment activities surged to CNY 1,005,080,736.34 in Q1 2025, compared to CNY 166,121,875.22 in Q1 2024, indicating a significant increase of over 505%[27]. - Cash inflow from financing activities totaled CNY 210,500,000.00 in Q1 2025, up from CNY 120,980,000.00 in Q1 2024, marking an increase of approximately 74%[27]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 101,544[9]. - The top three shareholders held a combined 26.37% of the company's shares, with the largest being Fujian Energy Group Co., Ltd. at 9.78%[9]. - The company plans to distribute a cash dividend of RMB 0.0124 per share, totaling RMB 27,039,060.56, which represents 31.90% of the net profit attributable to shareholders for the year 2024[11]. Research and Development - Research and development expenses for Q1 2025 were CNY 10.62 million, up from CNY 9.70 million in Q1 2024[23]. - The company incurred research and development expenses of ¥3.09 million in Q1 2025, slightly down from ¥3.53 million in Q1 2024[33]. Legal and Operational Issues - The company is facing a legal dispute involving its subsidiary, which is currently under review by the Fujian Provincial High Court[14]. - The company has decided to postpone the implementation of certain fundraising investment projects, specifically the water lily pharmaceutical project, while seeking to optimize the plan[12]. Other Financial Metrics - The company's goodwill decreased to RMB 7,639,511.13 from RMB 8,016,275.74, reflecting a decline of approximately 4.71%[17]. - Other comprehensive income after tax for Q1 2025 was CNY 310.20 thousand, compared to a loss of CNY 1.06 million in Q1 2024[24]. - The company's cash and cash equivalents increased to RMB 765,274,414.57 from RMB 653,602,726.44 as of December 31, 2024, reflecting a growth of approximately 17.06%[16].